Related Practice Life Sciences & Pharma The COVID-19 Disease Progression Monitor delivers evidence on the effects of the disease on services, systems and therapies 01262022170133
Executive Insights Life Sciences & Pharma When Is It Too Late? Drivers of Commercial Performance for Late Entrants in Biopharma April 28, 2025
Case Study Life Sciences & Pharma Unlocking the Potential of Next-Generation PROTACs: A Strategic Roadmap for R&D Investment March 7, 2025 Our client engaged L.E.K. Consulting to develop a market overview across multiple key therapeutic areas (e.g., oncology, immunology, neuroscience) and…
Executive Insights Life Sciences & Pharma Understanding the Inflation Reduction Act Negotiation Prices After the Dust Has Settled September 27, 2024